Faron Pharmaceuticals Oy (LON:FARN) Share Price Crosses Below 50 Day Moving Average – Here’s What Happened

Faron Pharmaceuticals Oy (LON:FARN) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 44.25 and traded as low as GBX 42.50. Faron Pharmaceuticals Oy shares last traded at GBX 43.95, with a volume of 17,943 shares.

Faron Pharmaceuticals Oy Trading Up 1.0%

The business has a 50 day moving average of GBX 44.25 and a 200-day moving average of GBX 97.66. The company has a current ratio of 0.84, a quick ratio of 1.09 and a debt-to-equity ratio of -133.35. The firm has a market capitalization of £87.69 million, a P/E ratio of -1.99 and a beta of 1.11.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.